Static
‘Theranos But Real’: New Blood-Testing Startup Says It Can Predict Health Risks
First reported by The Information ·
The signal
●○○○
Brief pending · reported by The Information, the single source so far
What happened
With all the renewed interest around the saga of Theranos, two startup founders, Omar Abudayyeh and Jonathan Gootenberg, made the tongue-in-cheek decision to plunk down about $12 for the rights to the...
Source description shown. AI brief pending.